SciClone Pharmaceuticals

SciClone is a US-based, China-focused specialty pharmaceutical company with a substantial revenue-generating and profitable commercial business and a broad, marketed product portfolio of differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.

Type
Public
HQ
Foster City, US
Founded
1989
Size (employees)
590 (est)
SciClone Pharmaceuticals was founded in 1989 and is headquartered in Foster City, US

SciClone Pharmaceuticals Office Locations

SciClone Pharmaceuticals has office in Foster City
Foster City, US

SciClone Pharmaceuticals Metrics

SciClone Pharmaceuticals Summary

Market capitalization

$493 M

Closing share price

$9.75
SciClone Pharmaceuticals's current market capitalization is $493 M.

SciClone Pharmaceuticals Financials

SciClone Pharmaceuticals's revenue is $157 M in FY, 2015 which is a 16.67% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

$157 M$135 M$127 M

Revenue growth, %

16.7%6.1%

Operating income

$29.9 M$26 M$10.4 M

Net Income

$29.5 M$25.2 M$11 M

Operating cash flow

$15.2 M$425 K$1.58 M

SciClone Pharmaceuticals Market Value History

SciClone Pharmaceuticals Company Life

You may also be interested in